Related Experiment Video
Updated: Jan 4, 2026
08:50
Deep Neuromuscular Blockade Leads to a Larger Intraabdominal Volume During Laparoscopy
Published on: June 25, 2013
13.6K
How to optimize neuromuscular blockade in ambulatory setting?
Claude Meistelman1, Benoit Plaud2, Bertrand Debaene3
1Department of Anaesthesia and Intensive Care Medicine, Hopital de Brabois, Université de Lorraine, Vandoeuvre.
Current Opinion in Anaesthesiology
|November 6, 2019
Summary
Neuromuscular blocking agents (NMBAs) are crucial for ambulatory surgery, improving intubation and ventilation. Routine neuromuscular monitoring and reversal agents prevent residual paralysis, ensuring patient safety during recovery.
Area of Science:
- Anesthesiology
- Surgical Pharmacology
Background:
- Ambulatory surgery is expanding, necessitating advanced anesthetic techniques.
- Neuromuscular blocking agents (NMBAs) are essential for optimizing surgical conditions and patient ventilation.
Purpose of the Study:
- To review the optimal use of NMBAs in ambulatory surgery.
- To update on neuromuscular monitoring and prevention of residual paralysis.
Main Methods:
- Review of current literature on NMBA use and monitoring in ambulatory settings.
- Analysis of evidence regarding neuromuscular blockade depth and reversal strategies.
Main Results:
- NMBAs improve intubating conditions and ventilation, acting as a solution, not a cause, of airway issues.
- Deep neuromuscular block is important for laparoscopic surgery; further research is needed to define optimal levels.
- Consensus supports perioperative objective neuromuscular monitoring and reversal agents to prevent residual paralysis and complications.
Conclusions:
- Current data indicate precise control of neuromuscular blockade is achievable.
- Optimal relaxation can be tailored to surgical needs, ensuring rapid and safe recovery.
Related Concept Videos
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
834
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
834
01:31Skeletal Muscle Relaxants: Therapeutic Uses
840
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
840
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
730
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
730
01:19Depolarizing Blockers: Pharmocokinetics
538
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
538
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
2.7K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
2.7K
01:21Skeletal Muscle Relaxants: Adverse Effects
745
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
745